Streetbeat News

Regulatory

AKLI

Trading in AKLI was halted at 7:57:37 a.m. ET due to pending news. Investors should stay tuned for further updates.

Portfolio Pulse from Benzinga Newsdesk

May 29, 2024 | 11:57 am

RSLS

ReShape Lifesciences Inc. (NASDAQ:RSLS) saw its stock surge over 100% in pre-market trading after receiving approval from the U.S. Patent And Trademark Office for its obesity treatment devices. The approval is subject to a fee due on Aug. 26, 2024. This comes amid increasing demand for weight-loss drugs like Ozempic and WeGovy. At the time of writing, RSLS was trading 82.87% higher at $0.380.

Portfolio Pulse from Pooja Rajkumari

May 29, 2024 | 11:49 am

JAZZ

Jazz Pharmaceuticals' zanidatamab has been granted FDA Priority Review for the treatment of advanced HER2-positive biliary tract cancer. The FDA has set a target action date of November 29, 2024.

Portfolio Pulse from Benzinga Newsdesk

May 29, 2024 | 11:47 am

FFIE

Faraday Future Intelligent Electric shares are trading lower after the company reported worse-than-expected FY23 sales results and announced the withdrawal of its production target guidance. Additionally, the company received a notice from Nasdaq for failing to timely file its Quarterly Report on Form 10-Q.

Portfolio Pulse from Benzinga Newsdesk

May 29, 2024 | 11:47 am

BA

ITA

PPA

Boeing Company (NYSE:BA) and a union representing its firefighters have reached a tentative contract agreement, potentially ending a lockout that began in early May. The agreement will be voted on Thursday, and if approved, firefighters will return to work on Saturday. Boeing's stock has declined over 14% in the past year, and the company is also negotiating with the International Association of Machinists and Aerospace Workers (IAM) for a new contract. Boeing's 737 MAX production has decreased due to intensified FAA inspections. Investors can gain exposure to Boeing via IShares U.S. Aerospace & Defense ETF (BATS:ITA) and Invesco Aerospace & Defense ETF (NYSE:PPA).

Portfolio Pulse from Shivani Kumaresan

May 29, 2024 | 11:45 am

AAL

GME

HOOD

QQQ

SPY

U.S. stocks are set to open lower due to rising bond yields and cooling meme stock rallies. Key retail earnings reports, Federal Reserve speeches, and geopolitical tensions are also influencing market sentiment. Notable premarket movements include American Airlines falling over 8% and Robinhood climbing over 4%.

Portfolio Pulse from Shanthi Rexaline

May 29, 2024 | 11:35 am

BITF

Trading halt status was updated at 7:25:00 AM ET, with details on quotation resumption and news resumption times.

Portfolio Pulse from Benzinga Newsdesk

May 29, 2024 | 11:25 am

MRK

Merck announced that the FDA has accepted a priority review for a new supplemental biologics license application for Keytruda in combination with chemotherapy for the first-line treatment of advanced or metastatic malignant pleural mesothelioma. The FDA's target action date is September 25, 2024.

Portfolio Pulse from Benzinga Newsdesk

May 29, 2024 | 11:20 am

RCKT

The European Commission has granted Orphan Medicinal Product Designation to Rocket Pharmaceuticals' RP-A601, an AAV.RH74-based gene therapy candidate for Plakophilin-2 related arrhythmogenic cardiomyopathy.

Portfolio Pulse from Benzinga Newsdesk

May 29, 2024 | 11:16 am

IMCR

Immunocore has announced the conversion of its TEBE-AM Phase 2/3 clinical trial into a Phase 3 trial for Kimmtrak, targeting previously treated advanced cutaneous melanoma, following consultation with the FDA.

Portfolio Pulse from Benzinga Newsdesk

May 29, 2024 | 11:14 am